{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T06:44:32Z","timestamp":1781592272818,"version":"3.54.5"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jiac-j.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.jiac.2018.02.011","type":"journal-article","created":{"date-parts":[[2018,3,16]],"date-time":"2018-03-16T23:26:28Z","timestamp":1521242788000},"page":"330-340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Antimicrobial susceptibility of common pathogens isolated from postoperative intra-abdominal infections in Japan"],"prefix":"10.1016","volume":"24","author":[{"given":"Yoshio","family":"Takesue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Kusachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshige","family":"Mikamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kiyota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuo","family":"Kaku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Hanaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Sumiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoi","family":"Uchino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Mizuguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyasu","family":"Ambo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Konosu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichiro","family":"Ishibashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihisa","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Hase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Harihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Okabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiko","family":"Seki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuo","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koshi","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minako","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoji","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhisa","family":"Uchiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junzo","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryohei","family":"Kawabata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Ohge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Akagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Oka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiro","family":"Wakatsuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsunori","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohji","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsunori","family":"Yanagihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2018.02.011_bib1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1086\/649554","article-title":"Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America","volume":"50","author":"Solomkin","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2018.02.011_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/sur.2016.261","article-title":"The surgical infection society revised guidelines on the management of intra-abdominal infection","volume":"18","author":"Mazuski","year":"2017","journal-title":"Surg Infect (Larchmt)"},{"key":"10.1016\/j.jiac.2018.02.011_bib3","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/CCM.0b013e31827e83af","article-title":"Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012","volume":"41","author":"Dellinger","year":"2013","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jiac.2018.02.011_bib4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13017-017-0141-6","article-title":"The management of intra-abdominal infections from a global perspective: 2017 WSES guidelines for management of intra-abdominal infections","volume":"12","author":"Sartelli","year":"2017","journal-title":"World J Emerg Surg"},{"key":"10.1016\/j.jiac.2018.02.011_bib5","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1093\/cid\/cit128","article-title":"Source control review in clinical trials of anti-infective agents in complicated intra-abdominal infections","volume":"56","author":"Solomkin","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2018.02.011_bib6","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jiac.2017.03.010","article-title":"Antimicrobial susceptibility of pathogens isolated from surgical site infections in Japan: comparison of data from nationwide surveillance studies conducted in 2010 and 2014-2015","volume":"23","author":"Takesue","year":"2017","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2018.02.011_bib7","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s10156-012-0509-1","article-title":"Nationwide surveillance of antimicrobial susceptibility patterns of pathogens isolated from surgical site infections (SSI) in Japan","volume":"18","author":"Takesue","year":"2012","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2018.02.011_bib8","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard","author":"Clinical and Laboratory Standards Institute","year":"2009"},{"key":"10.1016\/j.jiac.2018.02.011_bib9","unstructured":"EUCAST clinical breakpoints: http:\/\/www.eucast.org\/clinical_breakpoints\/. accessed 25 December 2017."},{"key":"10.1016\/j.jiac.2018.02.011_bib10","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/jac\/dkh166","article-title":"Characterization of HMRZ-86. a novel chromogenic cephalosporin for the detection of extended-spectrum beta-lactamases","volume":"53","author":"Hanaki","year":"2004","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2018.02.011_bib11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10096-005-0074-y","article-title":"Evaluation of a novel kit for the rapid detection of extendedspectrum beta-lactamase","volume":"25","author":"Colodner","year":"2006","journal-title":"Eur J Clin Microb Infect Dis"},{"key":"10.1016\/j.jiac.2018.02.011_bib12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1089\/sur.2007.041","article-title":"etal: choosing antibiotics for intra-abdominal infections: what do we mean by high risk","volume":"10","author":"Swenson","year":"2009","journal-title":"Surg Infect (Larchmt)"},{"key":"10.1016\/j.jiac.2018.02.011_bib13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/s12879-015-1054-1","article-title":"Empiric therapy for hospital-acquired, Gram-negative complicated intra-abdominal infection and complicated urinary tract infections: a systematic literature review of current and emerging treatment options","volume":"15","author":"Golan","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiac.2018.02.011_bib14","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1093\/cid\/civ707","article-title":"A\u00a0randomized, placebo-controlled trial of preemptive antifungal therapy for the prevention of invasive candidiasis following gastrointestinal surgery for intra-abdominal infections","volume":"61","author":"Knitsch","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2018.02.011_bib15","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/jama.2016.14655","article-title":"Empirical micafungin treatment and survival without invasive fungal infection in adults with ICU-acquired sepsis, Candida colonization, and multiple organ failure: the EMPIRICUS randomized clinical trial","volume":"316","author":"Timsit","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jiac.2018.02.011_bib16","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1128\/AAC.01365-09","article-title":"Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: a retrospective analysis","volume":"54","author":"Micek","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2018.02.011_bib17","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1097\/CCM.0b013e3181e96b91","article-title":"A\u00a0survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: a meta-analytic\/meta-regression study","volume":"38","author":"Kumar","year":"2010","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jiac.2018.02.011_bib18","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1001\/jama.2012.5833","article-title":"Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial","volume":"307","author":"Brunkhorst","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jiac.2018.02.011_bib19","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1128\/AAC.05186-14","article-title":"Trends in susceptibility of Escherichia coli from intra-abdominal infections to ertapenem and comparators in the United States according to data from the SMART program, 2009 to 2013","volume":"5","author":"Lob","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2018.02.011_bib20","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.3201\/eid2211.160519","article-title":"Global Escherichia coli sequence type 131 clade with blaCTX-M-27 Gene","volume":"22","author":"Matsumura","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jiac.2018.02.011_bib21","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1128\/AAC.00956-15","article-title":"Antimicrobial susceptibilities of aerobic and facultative gram-negative bacilli from intra-abdominal infections in patients from seven regions in China in 2012 and 2013","volume":"60","author":"Zhang","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2018.02.011_bib22","article-title":"Whole genome analysis of cephalosporin-resistant Escherichia coli from bloodstream infections in Australia, New Zealand and Singapore: high prevalence of CMY-2 producers and ST131 carrying blaCTX-M-15 and blaCTX-M-27","author":"Harris","year":"2017","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2018.02.011_bib23","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1186\/s12879-017-2873-z","article-title":"Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra-abdominal infection patients","volume":"17","author":"Zhang","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiac.2018.02.011_bib24","first-page":"67","article-title":"Epidemiology and antimicrobial susceptibility of Gram-negative aerobic bacteria causing intra-abdominal infections during 2010-2011","volume":"27","author":"Hawser","year":"2015","journal-title":"J\u00a0Chemother"},{"key":"10.1016\/j.jiac.2018.02.011_bib25","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1128\/JCM.43.6.2955-2958.2005","article-title":"Gene mutations responsible for overexpression of AmpC beta-lactamase in some clinical isolates of Enterobacter cloacae","volume":"43","author":"Kaneko","year":"2005","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.jiac.2018.02.011_bib26","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1586\/14787210.6.6.805","article-title":"Cefepime: a reappraisal in an era of increasing antimicrobial resistance","volume":"6","author":"Endimiani","year":"2008","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.jiac.2018.02.011_bib27","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ijantimicag.2012.10.022","article-title":"Characterisation and clinical features of Enterobacter cloacae bloodstream infections occurring at a tertiary care university hospital in Switzerland: is cefepime adequate therapy?","volume":"41","author":"Hilty","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiac.2018.02.011_bib28","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jiac.2017.05.010","volume":"23","author":"Yanagihara","year":"2017","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2018.02.011_bib29","doi-asserted-by":"crossref","first-page":"623e33","DOI":"10.1016\/j.jiac.2015.05.014","article-title":"Japanese nationwide surveillance in 2011 of antibacterial susceptibility patterns of clinical isolates from complicated urinary tract infection cases","volume":"21","author":"Ishikawa","year":"2015","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2018.02.011_bib30","doi-asserted-by":"crossref","DOI":"10.1086\/653053","article-title":"Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia","volume":"51","author":"Jones","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2018.02.011_bib31","article-title":"SENTRY Participant Group North America. Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: a report from the SENTRY Antimicrobial Surveillance Program (North America)","volume":"40","author":"Mathai","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2018.02.011_bib32","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1086\/341930","article-title":"Intra-abdominal anaerobic infections: bacteriology and therapeutic potential of newer antimicrobial carbapenem, fluoroquinolone, and desfluoroquinolone therapeutic agents","volume":"35","author":"Goldstein","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2018.02.011_bib33","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/jac\/dkp005","article-title":"Clinical and microbiological profiles of community-acquired and nosocomial intra-abdominal infections: results of the French prospective, observational EBIIA study","volume":"63","author":"Montravers","year":"2009","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"50","key":"10.1016\/j.jiac.2018.02.011_bib34","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1086\/647940","article-title":"Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007)","author":"Snydman","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2018.02.011_bib35","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/cid\/cir664","article-title":"Clinical efficacy and correlation of clinical outcomes with in\u00a0vitro susceptibility for anaerobic bacteria in patients with complicated intra-abdominal infections treated with moxifloxacin","volume":"53","author":"Goldstein","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2018.02.011_bib36","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1742-1241.2011.02839.x","article-title":"Moxifloxacin monotherapy for treatment of complicated intra-abdominal infections: a meta-analysis of randomised controlled trials","volume":"66","author":"Mu","year":"2012","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jiac.2018.02.011_bib37","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s10096-016-2691-z","article-title":"Enhanced loading regimen of teicoplanin is necessary to achieve therapeutic pharmacokinetics levels for the improvement of clinical outcomes in patients with renal dysfunction","volume":"35","author":"Ueda","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2018.02.011_bib38","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ijantimicag.2015.05.012","article-title":"Clinical response and mortality in tigecycline complicated intra-abdominal infection and complicated skin and soft-tissue infection trials","volume":"46","author":"Bassetti","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiac.2018.02.011_bib39","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1093\/cid\/civ097","article-title":"Ceftolozane\/tazobactam plus metronidazole for complicated intra-abdominal infections in an era of multidrug resistance: results from a randomized, double-blind, phase 3 trial (ASPECT-cIAI)","volume":"60","author":"Solomkin","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2018.02.011_bib40","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1093\/cid\/ciw133","article-title":"Efficacy and safety of ceftazidime-avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infection: results from a randomized, controlled, double-blind, phase 3 program","volume":"62","author":"Mazuski","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2018.02.011_bib41","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/cid\/ciw243","article-title":"Ceftazidime\/avibactam and ceftolozane\/tazobactam: second-generation \u03b2-Lactam\/\u03b2-Lactamase inhibitor combinations","volume":"63","author":"van Duin","year":"2016","journal-title":"Clin Infect Dis"}],"updated-by":[{"DOI":"10.1016\/j.jiac.2018.05.011","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000}}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X1830076X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X1830076X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T21:12:03Z","timestamp":1751490723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X1830076X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S1341321X1830076X"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2018.02.011","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.jiac.2018.05.011","asserted-by":"object"}]},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial susceptibility of common pathogens isolated from postoperative intra-abdominal infections in Japan","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2018.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}